Company Filing History:
Years Active: 2003-2012
Title: The Innovative Contributions of Carl Thibault
Introduction
Carl Thibault is a notable inventor based in Mascouche, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymatic activities. With a total of eight patents to his name, Thibault's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents, Thibault has developed inhibitors of histone deacetylase. This invention relates to the inhibition of histone deacetylase enzymatic activity, providing compounds and methods for treating cell proliferative diseases and conditions. Another significant patent involves novel heteroaryl compounds that serve as selective inhibitors of the human P2Y receptor. This invention also includes various pharmaceutical compositions and methods for treating diseases responsive to modulation of P2Y receptor activity.
Career Highlights
Throughout his career, Carl Thibault has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Methylgene, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.
Collaborations
Thibault has collaborated with several professionals in his field, including Rejean Ruel and Daniel Delorme. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Carl Thibault's innovative work in the pharmaceutical sector demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving treatment options for patients.